7-AZASPIRO[3.5]NONANE-7-CARBOXAMIDE COMPOUNDS
    7.
    发明申请
    7-AZASPIRO[3.5]NONANE-7-CARBOXAMIDE COMPOUNDS 审中-公开
    7-AZASPIRO [3.5] NONANE-7-羧酰胺化合物

    公开(公告)号:US20100113465A1

    公开(公告)日:2010-05-06

    申请号:US12573897

    申请日:2009-10-06

    CPC分类号: C07D403/14 C07D403/12

    摘要: Provided herein are 7-azaspiro[3.5]nonane-7-carboxamide compounds and the pharmaceutically acceptable salts of such compounds useful in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity, conditions including including acute pain, chronic pain, neuropathic pain, nociceptive pain, inflammatory pain, cancer and cancer pain, fibromyalgia, rheumatoid arthritis, inflammatory bowel disease, lupus, diabetes, allergic asthma, vascular inflammation, urinary incontinence, overactive bladder, emesis, cognitive disorders, anxiety, depression, sleeping disorders, eating disorders, movement disorders, glaucoma, psoriasis, multiple sclerosis, cerebrovascular disorders, brain injury, gastrointestinal disorders, hypertension, or cardiovascular disease.

    摘要翻译: 本文提供的是7-氮杂螺[3.5]壬烷-7-甲酰胺化合物和可用于治疗与脂肪酰胺水解酶(FAAH)活性相关的疾病或病症的化合物的药学上可接受的盐,包括急性疼痛,慢性疼痛,神经性 疼痛,伤害性疼痛,炎性疼痛,癌症和癌症疼痛,纤维肌痛,类风湿性关节炎,炎性肠病,狼疮,糖尿病,过敏性哮喘,血管炎症,尿失禁,膀胱过度活动,呕吐,认知障碍,焦虑症,抑郁症,睡眠障碍, 饮食失调,运动障碍,青光眼,牛皮癣,多发性硬化,脑血管障碍,脑损伤,胃肠道疾病,高血压或心血管疾病。